Siemens Healthcare Diagnostics is pleased to announce the forthcoming 2009 Panel Update. The panels and software in this update introduce new features that enhance resistance detection and improve workflow in your laboratory. Key new features included on the Gram Positive Overnight panels are the Inducible Clindamycin Test (ICd) and Cefoxitin screen (CfxS). Gram Negative panels feature Tigecycline and lowered dilutions of carbapenems.

A must for today’s busy microbiology laboratory,
the MicroScan® LabPro Information Manager is a simple, yet powerful informatics solution that streamlines workflow. The LabPro System will keep your data organized, while enabling
you to meet ever-increasing demands on your time.

The key benefits of MicroScan technology are direct MIC methodology, for optimal detection of emerging and low-level resistance, visual read capability for added confidence of unusual AST results, and convenient room temperature storage.


The Inducible Clindamycin Test (ICd) enhances the detection of clindamycin resistance in staphylococci not demonstrated in routine testing, and removes the need for manual D-Test. The new Cefoxitin Screen (CfxS) enhances oxacillin resistance detection for staphylococci¹. These new tests provide you with reduced incubation times, improved workflow, and faster reporting times.

Tigecycline, the first antibiotic within the new Glycylcycline class, is structurally similar to the tetracycline class of antibiotics. Tigecycline is targeted for use in treatment of multi-drug resistant Enterobacteriaceae.

With this new panel introduction, Siemens Healthcare Diagnostics continues to offer lower dilutions of vancomycin for optimal therapeutic monitoring of staphylococcal infections as well as lower dilutions of carbapenems for improved detection of KPC-producing isolates.